Showcase Sponsor

Vaxart is a privately held, clinical-stage company developing tablet vaccines. The company’s proprietary delivery platform is suitable to deliver any recombinant vaccine in oral form and allows rapid development to address emerging threats. Vaxart vaccines can be conveniently self-administered, with no cold chain distribution requirements and no medical waste.